Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00073671 · ClinicalTrials.gov registry record · NA
Prevention of Depression in At-Risk Adolescents
A NA study of Depression, sponsored by Vanderbilt University.
- Completed
- Registry status
- NA
- Development phase
- 316
- Enrollment target
- 4
- Study locations
NCT00073671: Completed NA study of Depression, sponsored by Vanderbilt University.
NCT00073671 is a NA study of Depression that has completed, run by Vanderbilt University. The registered enrollment target is 316 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (60% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00073671, a NA study of Depression, has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- NA
- Development phase
- 316 participants
- Enrollment target
- 4
- Study locations
Study Summary
This study examines the impact of a group cognitive behavioral program aimed at preventing depressive disorders and symptoms in adolescents at risk for developing depression.
Primary Outcome
a score of 4 or greater is considered an onset
Conditions Studied
Interventions
- OTHER Usual care
- BEHAVIORAL Cognitive-behavioral prevention program
Study Locations (4)
Massachusetts
- Harvard University Medical School - Boston
Oregon
- Kaiser Permanente Center for Health Research - Portland
Pennsylvania
- University of Pittsburgh Medical Center - Pittsburgh
Tennessee
- Vanderbilt University - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 316 participants |
| Start Date | 2003-03 |
| Est. Completion | 2009-01 |
| Phase | NA |
What the finished NCT00073671 record still lists
NCT00073671 is an interventional study that assigns participants to a tested intervention. The registered 316 participants enrollment target is mid-sized for trials with a published cap, below the 786-participant average among 679 other Depression trials with a reported enrollment target (60% lower).
The record links to 1 condition, with Depression appearing as the primary indexed condition, and to 2 interventions - of which Usual care is the first listed.
NCT00073671 reports a single indexed study location in Massachusetts, Oregon, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00073671 about?
NCT00073671 is a clinical study titled "Prevention of Depression in At-Risk Adolescents". This study examines the impact of a group cognitive behavioral program aimed at preventing depressive disorders and symptoms in adolescents at risk for developing depression.
What is the current status of trial NCT00073671?
This trial is currently completed. It is a NA study. The enrollment target is 316 participants. The study started on 2003-03. Estimated completion is 2009-01.
What conditions does trial NCT00073671 study?
This clinical trial studies the following conditions: Depression.
What interventions are being tested in trial NCT00073671?
The interventions under investigation include: Usual care (OTHER), Cognitive-behavioral prevention program (BEHAVIORAL).
Who is sponsoring clinical trial NCT00073671?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00073671 being conducted?
This trial has 4 study locations across Massachusetts, Oregon, Pennsylvania, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00073671's enrollment target sits among peer trials
316 132nd of 679 higher than 548 of 679 other Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
Cold and Heat Investigation to Lower Levels of Depression
RECRUITING · NA
-
Dosing rTMS for Depression Post-SCI
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04256317 · 316 participants · Phase 2
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
- NCT04787042 · 316 participants · Phase 1
Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
- NCT04802759 · 316 participants · Phase 1
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer
- NCT05464056 · 316 participants · NA
BUILT Family Lifestyle Program for Children with ADHD
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia